(S)-1,2-Diaminopropane-N,N,N',N'-tetraacetic acid, 95.0%, 5g

5-Chloroquinoline, 95.0%, 10g

5-FLUOROPYRIDINE-3-CARBOTHIOAMIDE, 95.0%, 100mg

3-VINYL BENZOIC ACID ETHYL ESTER, 95.0%, 1g

cis-4-Aminocyclohexanecarbonitrile hydrochloride, 97%, 500mg

2-Chloro-5-fluoronicotinonitrile, 95.0%, 25g

3,4-DIHYDRO-6-[[4-[[[3-(METHYLSULFONYL)PHENYL]METHYL]AMINO]-5-(TRIFLUOROMETHYL)-PYRIMIDIN-2-YL]AMINO]-2(1H)-QUINOLINONE, 98%, 25mg

6-Methyl-5-((3-(2-(methylthio)pyrimidin-4-yl)pyridin-2-yl)oxy)naphthalen-1-amine, 98%, 500mg

Ethyl 2-[4-(trifluoromethoxy)phenoxy]acetate, 25g

GC capillary column ROTI®Cap-5, 10 m, 0.32 mm, 0.10 µm, 1 Piece(s)

Butylmalonic Acid>98.0%(GC)(T)25g

Z-D-Tyr-OH, 95.0%, 500g

Ethyl 1,3-Dithiane-2-carboxylate>98.0%(GC)5g